Vera Therapeutics, Inc. — Director's Dealing 2021

May 19, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Vera Therapeutics, Inc. (VERA)
CIK: 0001831828
Period of Report: 2021-05-18

Reporting Person: SEIDENBERG BETH C (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-05-18	Class A Common Stock	C	423642	—	Acquired	423642	Indirect
2021-05-18	Class A Common Stock	C	100526	—	Acquired	524168	Indirect
2021-05-18	Class A Common Stock	C	818984	—	Acquired	1343152	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-05-18	Series A Preferred Stock	$	C	423642	Disposed		Class A Common Stock (423642)	Indirect
2021-05-18	Series B Preferred Stock	$	C	100526	Disposed		Class A Common Stock (100526)	Indirect
2021-05-18	Series C Preferred Stock	$	C	818984	Disposed		Class A Common Stock (818984)	Indirect

Footnotes

F1: The Series A Preferred Stock automatically converted into Class A Common Stock on a 11.5869:1 basis (on an adjusted basis, after giving effect to the reverse stock split of the Class A Common Stock effected by the Issuer on May 7, 2021) and had no expiration date.

F2: Consists of 409,620 shares of Class A Common Stock held by Kleiner Perkins Caufield & Byers XVI, LLC ("KPCB XVI") and 14,022 shares of Class A Common Stock held by KPCB XVI Founders Fund, LLC ("XVI Founders"). All shares are held for convenience in the name of "KPCB Holdings, Inc., as nominee". The managing member of KPCB XVI is KPCB XVI Associates, LLC ("XVI Associates"). L. John Doerr, Beth Seidenberg, Randy Komisar, Theodore E. Schlein and Wen Hsieh, the managing members of KPCB XVI Associates, exercise shared voting and dispositive control over the shares held by KPCB XVI. Such managing members disclaim beneficial ownership of all shares held by KPCB XVI except to the extent of their pecuniary interest therein.

F3: The Series B Preferred Stock automatically converted into Class A Common Stock on a 11.5869:1 basis (on an adjusted basis, after giving effect to the reverse stock split of the Class A Common Stock effected by the Issuer on May 7, 2021) and had no expiration date.

F4: Consists of 506,819 shares of Class A Common Stock held by KPCB XVI and 17,349 shares of Class A Common Stock held by XVI Founders. All shares are held for convenience in the name of "KPCB Holdings, Inc., as nominee". The managing member of KPCB XVI is XVI Associates. L. John Doerr, Beth Seidenberg, Randy Komisar, Theodore E. Schlein and Wen Hsieh, the managing members of KPCB XVI Associates, exercise shared voting and dispositive control over the shares held by KPCB XVI. Such managing members disclaim beneficial ownership of all shares held by KPCB XVI except to the extent of their pecuniary interest therein.

F5: The Series C Preferred Stock automatically converted into Class A Common Stock on a 11.5869:1 basis (on an adjusted basis, after giving effect to the reverse stock split of the Class A Common Stock effected by the Issuer on May 7, 2021) and had no expiration date.

F6: Consists of 1,298,695 shares of Class A Common Stock held by KPCB XVI and 44,457 shares of Class A Common Stock held by XVI Founders. All shares are held for convenience in the name of "KPCB Holdings, Inc., as nominee". The managing member of KPCB XVI is XVI Associates. L. John Doerr, Beth Seidenberg, Randy Komisar, Theodore E. Schlein and Wen Hsieh, the managing members of KPCB XVI Associates, exercise shared voting and dispositive control over the shares held by KPCB XVI. Such managing members disclaim beneficial ownership of all shares held by KPCB XVI except to the extent of their pecuniary interest therein.

F7: Consisted of 409,620 shares of Class A Common Stock that was automatically converted from the Issuer's Series A Preferred Stock held by KPCB XVI and 14,022 shares of Class A Common Stock that was automatically converted from the Issuer's Series A Preferred Stock held by XVI Founders.

F8: Consisted of 97,199 shares of Class A Common Stock that was automatically converted from the Issuer's Series B Preferred Stock held by KPCB XVI and 3,327 shares of Class A Common Stock that was automatically converted from the Issuer's Series B Preferred Stock held by XVI Founders.

F9: Consisted of 791,876 shares of Class A Common Stock that was automatically converted from the Issuer's Series C Preferred Stock held by KPCB XVI and 27,108 shares of Class A Common Stock that was automatically converted from the Issuer's Series C Preferred Stock held by XVI Founders.